Genotype in BRCA-associated breast cancers

Breast Journal

Volumn 19, Issue 1, 2013, Pages 87-91

  Meric Bernstam, Funda ^a   Gutierrez Barrera, Angelica M ^a   Litton, Jennifer ^a   Mellor Crummey, Lauren ^a   Ready, Kaylene ^a   Gonzalez Angulo, Ana Maria ^a   Lu, Karen H ^a   Hortobagyi, Gabriel N ^a   Arun, Banu K ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

BRCA; Breast cancer; Genotype

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RISK; FEMALE; GENE MUTATION; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; PROSPECTIVE STUDY;

3' FLANKING REGION; 5' FLANKING REGION; ADULT; AGED; BREAST NEOPLASMS; CHI-SQUARE DISTRIBUTION; FEMALE; GENES, BRCA1; GENES, BRCA2; GENOTYPE; GERM-LINE MUTATION; HUMANS; MIDDLE AGED; PHENOTYPE; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84872269241     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/tbj.12056     Document Type: Article

References (12)

1. Antoniou A, Pharoah PD, Narod S, et al,. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 2003; 72: 1117-30.
2. Brose MS, Rebbeck TR, Calzone KA, Stopfer JE, Nathanson KL, Weber BL,. Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program. J Natl Cancer Inst 2002; 18: 1365-72.
3. Ford D, Easton DF, Stratton M, et al,. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 1998; 62: 676-89.
4. Struewing JP, Hartge P, Wacholder S, et al,. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 1997; 336: 1401-8.
5. Gayther SA, Mangion J, Russell P, et al,. Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene. Nat Genet 1997; 15: 103-5.
6. Risch HA, McLaughlin JR, Cole DE, et al,. Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada. J Natl Cancer Inst 2006; 98: 1694-706.
7. Gayther SA, Warren W, Mazoyer S, et al,. Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation. Nat Genet 1995; 11: 428-33.
8. Lubinski J, Phelan CM, Ghadirian P, et al,. Cancer variation associated with the position of the mutation in the BRCA2 gene. Fam Cancer 2004; 3: 1-10.
9. Chen HX, Mooney M, Boron M, et al,. Phase II multicenter trial of bevacizumab plus fluorouracil and leucovorin in patients with advanced refractory colorectal cancer: an NCI Treatment Referral Center Trial TRC-0301. J Clin Oncol 2006; 24: 3354-60.
10. Gronwald J, Huzarski T, Byrski B, et al,. Cancer risks in first degree relatives of BRCA1 mutation carriers: effects of mutation and proband disease status. J Med Genet 2006; 43: 424-8.
11. Antoniou AC, Beesley J, McGuffog L, et al,. Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction. Cancer Res 2010; 70: 9742-54.
12. Antoniou AC, Wang X, Fredericksen ZS, et al,. A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population. Nat Genet 2010; 42: 885-92.